Skip to content
User

Eric H. Schoenstein

Jensen Investment Management

Eric H. Schoenstein Bio-Techne Corp stake

total: 257

Jensen Investment Management TECH trades

Total transactions:
7
New positions:
1
Sold out:
1
Added:
3
Reduced:
2
Held since:
2023 Q1
Held for:
10 quarters
Latest activity:
2025 Q3
According to 2026 Q2 report, Eric H. Schoenstein doesn't hold any Bio-Techne Corp (TECH) shares. To date, the estimated cost basis is nearly $74.65 for "buy" trades and estimated average "sell" price is $52.81. Jensen Investment Management first purchased TECH in 2023 Q1, initially acquiring 37,270 shares. Since the initial investment in Bio-Techne Corp (TECH), Jensen Investment Management has made 6 more transactions.

When did Eric H. Schoenstein sell Bio-Techne Corp (TECH)?

Eric H. Schoenstein sold off the entire Bio-Techne Corp (TECH) position in 2025 Q3.

When did Eric H. Schoenstein buy Bio-Techne Corp (TECH)?

Eric H. Schoenstein first invested in Bio-Techne Corp (TECH) in 2023 Q1 at the reported quarter-end price of $72.43 per share.

What's the cost basis of Jensen Investment Management's TECH stake?

The estimated cost basis for Bio-Techne Corp (TECH) stake is around $74.65 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$74.65
Weighted AVG sell price:
$52.81

Eric H. Schoenstein's historical trades in Bio-Techne Corp

7 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2025 Q3
0.00%
0
$51.45
-100% (-47,450)
-0.03%
2025 Q1
0.03%
47,450
$58.63
$2,781,994
-13.35% (-7,310)
-0%
2024 Q3
0.04%
54,760
$79.93
$4,376,967
+5.19% (+2,700)
+0%
2023 Q4
0.03%
52,060
$77.16
$4,016,950
+23.95% (+10,060)
+0.01%
2023 Q3
0.02%
42,000
$68.07
$2,858,940
-3.29% (-1,430)
-0%
2023 Q2
0.03%
43,430
$81.63
$3,545,191
+16.53% (+6,160)
+0%
2023 Q1
0.02%
37,270
$72.43
$2,699,466
new
+0.02%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.